{"id":"W6977030307","doi":"10.6084/m9.figshare.12655466.v1","title":"Additional file 3 of Survival outcomes and clinical benefit in patients with acute myeloid leukemia treated with glasdegib and low-dose cytarabine according to response to therapy","year":2020,"lang":"en","type":"article","venue":"Figshare","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Cytarabine; Myeloid leukemia; Censoring (clinical trials); Confidence interval; Overall survival; Survival analysis; Ruxolitinib; Complete response","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00180396,0.0009730166,0.001616161,0.001933453,0.0007238718,0.001548628,0.001482292,0.0009850092,0.8141251],"category_scores_gemma":[0.03424291,0.0005302815,0.001255169,0.003148943,0.0001965322,0.001488664,0.0009788787,0.0009271906,0.08543626],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001222901,"about_ca_system_score_gemma":0.001698945,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006974745,"about_ca_topic_score_gemma":0.01434392,"domain_scores_codex":[0.998862,0.0001994268,0.0002569247,0.0002435314,0.0002444048,0.0001935809],"domain_scores_gemma":[0.972336,0.02054923,0.002826461,0.001115962,0.00251725,0.0006550794],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.001668896,0.0001883155,0.008753945,0.005325703,0.0002626605,0.0001158911,0.0000833873,0.0009959867,0.0001508887,0.0008136623,0.9681626,0.01347808],"study_design_scores_gemma":[0.03345172,0.001334419,0.1438558,0.0107309,0.001205866,0.00123989,0.0006643189,0.007438081,0.001366738,0.01296789,0.7853892,0.0003551542],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"dataset","genre_gemma":"empirical","genre_scores_codex":[0.0003372095,0.00001904624,0.00007682439,0.00008922892,0.00001280063,0.00007265226,0.9985422,0.00009587731,0.0007542294],"genre_scores_gemma":[0.01907042,0.0001787975,0.001901122,0.0006389682,0.0001427333,0.002531689,0.9650742,0.0004690855,0.009993079],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.8141251,"threshold_uncertainty_score":0.265128,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03455497549504653,"score_gpt":0.3027308503962501,"score_spread":0.2681758749012036,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}